SEC Form 3 · accession 0001144204-16-103220
PHASERX, INC. · PZRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Overell
Officer — President and CEO · Director
Period of report
May 17, 2016
Accepted (ET)
May 17, 2016 · 9:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429386
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | holding | — | — | — | 99,237 | I | By Foundation BioVentures LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3,F1 | $2.34 | holding | — | — | — | — | Sep 18, 2019 | Common Stock | 64,518 | — | D |
| Employee Stock Option (right to buy)F4,F1 | $0.11 | holding | — | — | — | — | Jun 13, 2024 | Common Stock | 48,423 | — | D |
Explanation of responses
- F1Reflects a 1-for-10.656096 reverse stock split effected on May 17, 2016.
- F2Dr. Overell is the sole member of Foundation BioVentures LLC and in such capacity holds voting and dispositive power over the shares and is deemed to beneficially own shares held by Foundation BioVentures LLC.
- F3The option vested and became exercisable in 1/48th equal installments on each monthly anniversary of August 17, 2009. The grant date of the option was September 18, 2009.
- F4The option vests in 1/48th equal installments on each monthly anniversary of the date of grant, subject to continued service to the Issuer. The grant date of the option was June 13, 2014 and the first installment became exercisable on July 13, 2014.